Henry Waxman actually said...

"I applaud the agency for finally taking formal action to change its LDT policy by issuing the notification of its impending guidance."

"Well, Mr. Chairman, I want to commend you on this hearing."

"we don't want to stifle innovation, we do want these LDTs to continue"

"For those improvements to be realized, we will need to rely on increasingly sophisticated tests that can both accurately analyze the genetic and molecular properties of diseases as expressed in indivi..."